Researchers are still conducting clinical trials that will test whether or not semaglutide can be an effective new treatment for AUD
Fasting blood glucose levels ranged from 101 to 139 mg/dL, and postprandial glucose levels ranged from 130 to 157 mg/d
Moreover, bone microarchitecture/strength changes assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) are lacking
Keywords MC4R deficiency , genetic obesity , GLP-1 receptor agonists , leptin-melanocortin pathway , weight management 0 1 INTRODUCTION Genetic obesity is broadly divided into syndromic obesity and non-syndromic obesity, both of which can be caused by monogenic, polygenic, or chromosomal abnormalities [1]
Un importante ensayo clnico, denominado ensayo SELECT y publicado en el New England Journal of Medicine , sigui a ms de 17 000 personas con sobrepeso u obesidad y cardiopata preexistente